Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers

被引：24

作者：

Acebes-Fernandez, Vanessa ^{[1
]}

Landeira-Vinuela, Alicia ^{[1
]}

Juanes-Velasco, Pablo ^{[1
]}

Hernandez, Angela-Patricia ^{[1
]}

Otazo-Perez, Andrea ^{[1
]}

Manzano-Roman, Raul ^{[2
]}

Gongora, Rafael ^{[1
]}

Fuentes, Manuel ^{[1
,2
]}

机构：

[1] USAL, Dept Med & Cytometry Gen Serv Nucleus, CIBERONC, CB16 12 00400,Canc Res Ctr,IBMCC,CSIC,IBSAL, Salamanca 37007, Spain

[2] USAL, Prote Unit, Canc Res Ctr, IBMCC,CSIC,IBSAL, Salamanca 37007, Spain

来源：

NANOMATERIALS | 2020年 / 10卷 / 07期

关键词：

nanomaterials; nanomedicine; immunotherapy; oncotherapy; immune-checkpoint inhibitors; immunogenic cell death; nano-vaccines; nano-conjugates; immune response; IMMUNOGENIC CELL-DEATH; ANTIGEN-PRESENTING CELLS; IMMUNE-CHECKPOINT BLOCKADE; TUMOR-ASSOCIATED ANTIGENS; ACTIVE SPECIFIC IMMUNOTHERAPY; IRON-OXIDE NANOPARTICLES; CYTOTOXIC T-LYMPHOCYTES; NATURAL-KILLER-CELLS; CANCER-IMMUNOTHERAPY; DENDRITIC CELLS;

D O I：

10.3390/nano10071274

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

The broad relationship between the immune system and cancer is opening a new hallmark to explore for nanomedicine. Here, all the common and synergy points between both areas are reviewed and described, and the recent approaches which show the progress from the bench to the beside to biomarkers developed in nanomedicine and onco-immunotherapy.

引用

页码：1 / 72

页数：72

共 387 条

[1] Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity [J].

Aaes, Tania Love ;

Kaczmarek, Agnieszka ;

Delvaeye, Tinneke ;

De Craene, Bram ;

De Koker, Stefaan ;

Heyndrickx, Liesbeth ;

Delrue, Iris ;

Taminau, Joachim ;

Wiernicki, Bartosz ;

De Groote, Philippe ;

Garg, Abhishek D. ;

Leybaert, Luc ;

Grooten, Johan ;

Bertrand, Mathieu J. M. ;

Agostinis, Patrizia ;

Berx, Geert ;

Declercq, Wim ;

Vandenabeele, Peter ;

Krysko, Dmitri V. .

CELL REPORTS, 2016, 15 (02) :274-287

[2] Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired [J].

Ahmadzadeh, Mojgan ;

Johnson, Laura A. ;

Heemskerk, Bianca ;

Wunderlich, John R. ;

Dudley, Mark E. ;

White, Donald E. ;

Rosenberg, Steven A. .

BLOOD, 2009, 114 (08) :1537-1544

[3] SELF-AGGREGATES OF HYDROPHOBIZED POLYSACCHARIDES IN WATER - FORMATION AND CHARACTERISTICS OF NANOPARTICLES [J].

AKIYOSHI, K ;

DEGUCHI, S ;

MORIGUCHI, N ;

YAMAGUCHI, S ;

SUNAMOTO, J .

MACROMOLECULES, 1993, 26 (12) :3062-3068

[4] Enhanced Gold Nanoparticle Based ELISA for a Breast Cancer Biomarker [J].

Ambrosi, Adriano ;

Airo, Federico ;

Merkoci, Arben .

ANALYTICAL CHEMISTRY, 2010, 82 (03) :1151-1156

[5] Foreign body reaction to biomaterials [J].

Anderson, James M. ;

Rodriguez, Analiz ;

Chang, David T. .

SEMINARS IN IMMUNOLOGY, 2008, 20 (02) :86-100

[6] HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection [J].

Andersson, Ulf ;

Tracey, Kevin J. .

ANNUAL REVIEW OF IMMUNOLOGY, VOL 29, 2011, 29 :139-162

[7] Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification [J].

Andreatta, Massimo ;

Karosiene, Edita ;

Rasmussen, Michael ;

Stryhn, Anette ;

Buus, Soren ;

Nielsen, Morten .

IMMUNOGENETICS, 2015, 67 (11-12) :641-650

[8]

[Anonymous], 2017, BEST (Biomarkers, EndpointS, and other Tools), P55, DOI DOI 10.1164/RCCM.201301-0153OC

[9]

[Anonymous], 2018, Pediatr. Blood Cancer

[10] Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma [J].

Antonia, SJ ;

Seigne, J ;

Diaz, J ;

Muro-Cacho, C ;

Extermann, M ;

Farmelo, MJ ;

Friberg, M ;

Alsarraj, M ;

Mahany, JJ ;

Pow-Sang, J ;

Cantor, A ;

Janssen, W .

JOURNAL OF UROLOGY, 2002, 167 (05) :1995-2000

← 1 2 3 4 5 6 7 8 9 10 →